Cargando…
Suppressed endothelin-1 by anti-VEGF therapy is important for patients with BRVO-related macular edema to improve their vision
BACKGROUND: Branch retinal vein occlusion (BRVO) commonly occurs at the arteriovenous crossing in the unilateral eye, and cardiovascular diseases can be risk factors of BRVO. However, the pathomechanism leading to BRVO is not yet clear. In addition to mechanical compression, the vein might locally c...
Autores principales: | Kida, Teruyo, Flammer, Josef, Oku, Hidehiro, Morishita, Seita, Fukumoto, Masanori, Suzuki, Hiroyuki, Konieczka, Katarzyna, Ikeda, Tsunehiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995759/ https://www.ncbi.nlm.nih.gov/pubmed/27559424 http://dx.doi.org/10.1186/s13167-016-0066-2 |
Ejemplares similares
-
Data on the involvement of endothelin-1 (ET-1) in the dysregulation of retinal veins
por: Kida, Teruyo, et al.
Publicado: (2018) -
Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021) -
Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion
por: Kida, Teruyo, et al.
Publicado: (2014) -
Vitreous estrogen levels in patients with an idiopathic macular hole
por: Inokuchi, Naoki, et al.
Publicado: (2015) -
Long-term evaluation of spontaneous release of epiretinal membrane and its possible pathogenesis
por: Kida, Teruyo, et al.
Publicado: (2017)